CDK9 and osteosarcoma: In Ma et al.’s study, CDK9 expression is inversely correlated to the percent of tumor necrosis post-neoadjuvant chemotherapy, an important predictive factor for disease outcomes in osteosarcoma patients and correlates with worse prognosis [14].